These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15135038)

  • 21. Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease.
    Kohm AP; Turley DM; Miller SD
    Int Rev Immunol; 2005; 24(5-6):361-92. PubMed ID: 16318987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell anergy.
    Macián F; Im SH; García-Cózar FJ; Rao A
    Curr Opin Immunol; 2004 Apr; 16(2):209-16. PubMed ID: 15023415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signal initiation in T-cell receptor microclusters.
    Seminario MC; Bunnell SC
    Immunol Rev; 2008 Feb; 221():90-106. PubMed ID: 18275477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signaling in the immunological synapse: defining the optimal size.
    Kupfer A
    Immunity; 2006 Jul; 25(1):11-3. PubMed ID: 16860751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathways of memory CD8+ T-cell development.
    Bannard O; Kraman M; Fearon D
    Eur J Immunol; 2009 Aug; 39(8):2083-7. PubMed ID: 19637204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological synapse and microclusters: the site for recognition and activation of T cells.
    Saito T; Yokosuka T
    Curr Opin Immunol; 2006 Jun; 18(3):305-13. PubMed ID: 16616469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-shaping the T cell repertoire: TCR editing and TCR revision for good and for bad.
    Wagner DH
    Clin Immunol; 2007 Apr; 123(1):1-6. PubMed ID: 16990051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a general function describing T cell proliferation.
    De Boer RJ; Perelson AS
    J Theor Biol; 1995 Aug; 175(4):567-76. PubMed ID: 7475092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection and fine-tuning of the autoimmune T-cell repertoire.
    Anderton SM; Wraith DC
    Nat Rev Immunol; 2002 Jul; 2(7):487-98. PubMed ID: 12094223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of serine/threonine kinases in T-cell activation.
    Matthews SA; Cantrell DA
    Curr Opin Immunol; 2006 Jun; 18(3):314-20. PubMed ID: 16603344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
    Ebert LM; Schaerli P; Moser B
    Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MHC restriction and allogeneic immune responses.
    Kazansky DB
    J Immunotoxicol; 2008 Oct; 5(4):369-84. PubMed ID: 19404871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell receptor stimulation, reactive oxygen species, and cell signaling.
    Williams MS; Kwon J
    Free Radic Biol Med; 2004 Oct; 37(8):1144-51. PubMed ID: 15451054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic regulation of notch 1 and notch 2 surface expression during T cell development and activation revealed by novel monoclonal antibodies.
    Fiorini E; Merck E; Wilson A; Ferrero I; Jiang W; Koch U; Auderset F; Laurenti E; Tacchini-Cottier F; Pierres M; Radtke F; Luther SA; Macdonald HR
    J Immunol; 2009 Dec; 183(11):7212-22. PubMed ID: 19915064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed expansion of a restricted T cell repertoire by low-density TCR ligands.
    Lavoie PM; Dumont AR; McGrath H; Kernaleguen AE; Sékaly RP
    Int Immunol; 2005 Jul; 17(7):931-41. PubMed ID: 15972304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.
    Fontenot JD; Rudensky AY
    Nat Immunol; 2005 Apr; 6(4):331-7. PubMed ID: 15785758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified T-cell receptor ligands: moving beyond a strict occupancy model for T-cell activation by antigen.
    Racioppi L; Germain RN
    Chem Immunol; 1995; 60():79-99. PubMed ID: 7857530
    [No Abstract]   [Full Text] [Related]  

  • 38. The golli-myelin basic protein negatively regulates signal transduction in T lymphocytes.
    Feng JM; Fernandes AO; Campagnoni CW; Hu YH; Campagnoni AT
    J Neuroimmunol; 2004 Jul; 152(1-2):57-66. PubMed ID: 15223237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling.
    Yasuda T; Bundo K; Hino A; Honda K; Inoue A; Shirakata M; Osawa M; Tamura T; Nariuchi H; Oda H; Yamamoto T; Yamanashi Y
    Int Immunol; 2007 Apr; 19(4):487-95. PubMed ID: 17329234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.